<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1210</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2007-0-2-5-11</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак почки</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Contemporary roll of organ-preserving surgery of renal cell carcinoma</article-title><trans-title-group xml:lang="ru"><trans-title>Роль органосохраняющего хирургического лечения рака почки на современном этапе</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Matveev</surname><given-names>V. B.</given-names></name><name xml:lang="ru"><surname>Матвеев</surname><given-names>В. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Matveev</surname><given-names>B. P.</given-names></name><name xml:lang="ru"><surname>Матвеев</surname><given-names>Б. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Volkova</surname><given-names>M. I.</given-names></name><name xml:lang="ru"><surname>Волкова</surname><given-names>М. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Perlin</surname><given-names>D. V.</given-names></name><name xml:lang="ru"><surname>Перлин</surname><given-names>Д. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Figurin</surname><given-names>K. M.</given-names></name><name xml:lang="ru"><surname>Фигурин</surname><given-names>К. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru">Отделение урологии РОНЦ им. Н.Н. Блохина РАМН</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Department of Renal Transplantation, Research Institute of Urology</institution></aff><aff><institution xml:lang="ru">Отделение трансплантации почки НИИ урологии</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2007-06-30" publication-format="electronic"><day>30</day><month>06</month><year>2007</year></pub-date><volume>3</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>5</fpage><lpage>11</lpage><history><date date-type="received" iso-8601-date="2020-02-20"><day>20</day><month>02</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-02-20"><day>20</day><month>02</month><year>2020</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/1210">https://oncourology.abvpress.ru/oncur/article/view/1210</self-uri><abstract xml:lang="en"><p><bold>Objective: </bold>to assess the results of organ-preserving treatment of patients with renal cell carcinoma (RCC).</p><p><bold>Materials and methods: </bold>238 patients with renal tumors underwent partial nephrectomy at our institution between 1971 and 2006. 35(14.7%) of 238 patients were showed to have benign histology. RCC was revealed in 203(85.3%) cases on pathological examination. The latter group was retrospectively analyzed.</p><p><bold>Results: </bold>The indications for partial nephrectomy included bilateral lesions in 28.6%, solitary kidney in 3.9%, solitary functioning kidney in 1.5%, horseshoe kidney in 4.9%. An elective partial nephrectomy was performed in 61.1% of the patients. Local stage T was considered as T1 in 68.7%, T2 Р in 24.2%, T3а Р in 6.6%, T3в Р in 0.5% cases. Among 58 patients with bilateral lesions T stage of the contralateral kidney was considered as T1 in 25.9%, T2 Р in 10.3%, T3а Р in 12.0%, T3b Р in 3.5%, Tх Р in 48.3% cases. Positive lymph nodes (N+) were found in 2 (1.5%), distant metastases (M1) in 5 (2,5%) patients. An open partial nephrectomy was performed in 92.1%, laparoscopic in 2.5%, bench surgery in 4.4% cases. In 82.2% cases of bilateral RCC the surgery was performed on both kidneys. Five (2.5%) patients with solitary metastasis were treated with liver resection (1), pulmonary resection (1), scapular resection (1), contralateral adrenalectomy(2). Early surgical complications which required surgery occurred in 6.9% cases. Acute renal failure that necessitates dialysis was registered in 3.9%, chronic renal insufficiency with programmed dialysis in 1.0% of the patients. Renal artery clamping for more than 30 minutes significantly increased the risk of renal failure. Local recurrences appeared in 8.9% (local in 2.5%, distant in 6.4%) patients at a median of 56.1(3—120) months following surgery. The width of the surgical margin has no impact on local recurrence rate. 5-year cancer-specific and relapse-free survival of the whole group of patients was 93.4% and 82.5%, respectively; in the subgroups of uniand bilateral lesion, these were 95.1% and 89.6%, and 91.5% and 75.2%, respectively (p&gt;0,05). T stage and presence of positive lymph nodes and distant metastases significantly influenced the survival.</p><p><bold>Conclusion: </bold>partial nephrectomy in patients with RCC has a low complication rate and provides an excellent long term survival in patients with localized disease.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Objective: </bold>to assess the results of organ-preserving treatment of patients with renal cell carcinoma (RCC).</p><p><bold>Materials and methods: </bold>238 patients with renal tumors underwent partial nephrectomy at our institution between 1971 and 2006. 35(14.7%) of 238 patients were showed to have benign histology. RCC was revealed in 203(85.3%) cases on pathological examination. The latter group was retrospectively analyzed.</p><p><bold>Results: </bold>The indications for partial nephrectomy included bilateral lesions in 28.6%, solitary kidney in 3.9%, solitary functioning kidney in 1.5%, horseshoe kidney in 4.9%. An elective partial nephrectomy was performed in 61.1% of the patients. Local stage T was considered as T1 in 68.7%, T2 Р in 24.2%, T3а Р in 6.6%, T3в Р in 0.5% cases. Among 58 patients with bilateral lesions T stage of the contralateral kidney was considered as T1 in 25.9%, T2 Р in 10.3%, T3а Р in 12.0%, T3b Р in 3.5%, Tх Р in 48.3% cases. Positive lymph nodes (N+) were found in 2 (1.5%), distant metastases (M1) in 5 (2,5%) patients. An open partial nephrectomy was performed in 92.1%, laparoscopic in 2.5%, bench surgery in 4.4% cases. In 82.2% cases of bilateral RCC the surgery was performed on both kidneys. Five (2.5%) patients with solitary metastasis were treated with liver resection (1), pulmonary resection (1), scapular resection (1), contralateral adrenalectomy(2). Early surgical complications which required surgery occurred in 6.9% cases. Acute renal failure that necessitates dialysis was registered in 3.9%, chronic renal insufficiency with programmed dialysis in 1.0% of the patients. Renal artery clamping for more than 30 minutes significantly increased the risk of renal failure. Local recurrences appeared in 8.9% (local in 2.5%, distant in 6.4%) patients at a median of 56.1(3—120) months following surgery. The width of the surgical margin has no impact on local recurrence rate. 5-year cancer-specific and relapse-free survival of the whole group of patients was 93.4% and 82.5%, respectively; in the subgroups of uniand bilateral lesion, these were 95.1% and 89.6%, and 91.5% and 75.2%, respectively (p&gt;0,05). T stage and presence of positive lymph nodes and distant metastases significantly influenced the survival.</p><p><bold>Conclusion: </bold>partial nephrectomy in patients with RCC has a low complication rate and provides an excellent long term survival in patients with localized disease.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Moinzadeh A., Gill A.M., Finelli A. et al. Laparoscopic partial nephrectomy: 3-year followup. J Urol 2006;175:459—62.</mixed-citation><mixed-citation xml:lang="ru">Moinzadeh A., Gill A.M., Finelli A. et al. Laparoscopic partial nephrectomy: 3-year followup. J Urol 2006;175:459—62.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Lau W.K., Blute M.L., Weaver A.L. et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 2000;75(12):1236—42.</mixed-citation><mixed-citation xml:lang="ru">Lau W.K., Blute M.L., Weaver A.L. et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 2000;75(12):1236—42.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Clark P.E., Schover L.R., Uzzo R.G. et al. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology 2001;57(2):252—6.</mixed-citation><mixed-citation xml:lang="ru">Clark P.E., Schover L.R., Uzzo R.G. et al. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology 2001;57(2):252—6.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Uzzo R.G., Novick A.C. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001;166(1):6—18.</mixed-citation><mixed-citation xml:lang="ru">Uzzo R.G., Novick A.C. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001;166(1):6—18.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Аляев Ю.Г., Крапивин А.А. Резекция почки при раке. М., Медицина; 2001. с. 42—51.</mixed-citation><mixed-citation xml:lang="ru">Аляев Ю.Г., Крапивин А.А. Резекция почки при раке. М., Медицина; 2001. с. 42—51.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Van Poppel H., Da Pozzo L., Albrecht W. et al. Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma. Eur Urol 2006 Nov 15; [Epub ahead of print].</mixed-citation><mixed-citation xml:lang="ru">Van Poppel H., Da Pozzo L., Albrecht W. et al. Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma. Eur Urol 2006 Nov 15; [Epub ahead of print].</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Hafez K.S., Fergany A.F., Novick A.C. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999;162(6):1930—3.</mixed-citation><mixed-citation xml:lang="ru">Hafez K.S., Fergany A.F., Novick A.C. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999;162(6):1930—3.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Patard J.J., Shvarts O., Lam J.S. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004;171(6 Pt 1):2181-5, quiz 2435.</mixed-citation><mixed-citation xml:lang="ru">Patard J.J., Shvarts O., Lam J.S. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004;171(6 Pt 1):2181-5, quiz 2435.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Leibovich B.C., Blute M.L., Cheville J.C. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 2004;171(3):1066—70.</mixed-citation><mixed-citation xml:lang="ru">Leibovich B.C., Blute M.L., Cheville J.C. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 2004;171(3):1066—70.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Frank I., Blute M.L., Cheville J.C. et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003;170(6 Pt 1):2217—20.</mixed-citation><mixed-citation xml:lang="ru">Frank I., Blute M.L., Cheville J.C. et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003;170(6 Pt 1):2217—20.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Jeschke K., Peschel R., Wakonig L. et al. Laparoscopic nephron-sparing surgery for renal tumors. Urology 2001;58:688—92.</mixed-citation><mixed-citation xml:lang="ru">Jeschke K., Peschel R., Wakonig L. et al. Laparoscopic nephron-sparing surgery for renal tumors. Urology 2001;58:688—92.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Rasweiler J., Abbou C., Janetschek G. et al. Laparoscopic partial nephrectomy, the European experience. Urol Clin North Am 2000;27:721—36.</mixed-citation><mixed-citation xml:lang="ru">Rasweiler J., Abbou C., Janetschek G. et al. Laparoscopic partial nephrectomy, the European experience. Urol Clin North Am 2000;27:721—36.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Winfield H.N., Donovan J.F., Lund G.O. et al. Laparoscopic partial nephrectomy: initial experience and comparison to the open surgical approach. J Urol 1995;153:1409—14.</mixed-citation><mixed-citation xml:lang="ru">Winfield H.N., Donovan J.F., Lund G.O. et al. Laparoscopic partial nephrectomy: initial experience and comparison to the open surgical approach. J Urol 1995;153:1409—14.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Desai M.M., Gill I.S., Kaouk J.H. et al. Laparoscopic partial nephrectomy with suture repair of the pelvicaliceal system. Urology 2003;61:99—104.</mixed-citation><mixed-citation xml:lang="ru">Desai M.M., Gill I.S., Kaouk J.H. et al. Laparoscopic partial nephrectomy with suture repair of the pelvicaliceal system. Urology 2003;61:99—104.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Novick A.C. Nephron-sparing surgery for renal cell carcinoma. Br J Urol 1998;82:321—4.</mixed-citation><mixed-citation xml:lang="ru">Novick A.C. Nephron-sparing surgery for renal cell carcinoma. Br J Urol 1998;82:321—4.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Li Q.L., Guan H.W., Zhang Q.P. Optimal margin in nephron-sparing surgery for renal cell carcinoma 4 cm or less. Eur Urol 2003;44(4):448—51.</mixed-citation><mixed-citation xml:lang="ru">Li Q.L., Guan H.W., Zhang Q.P. Optimal margin in nephron-sparing surgery for renal cell carcinoma 4 cm or less. Eur Urol 2003;44(4):448—51.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Piper N.Y., Bishoff J.T., Magee C. Is a 1-CM margin necessary during nephronsparing surgery for renal cell carcinoma? Urology 2001;58(6):849—52.</mixed-citation><mixed-citation xml:lang="ru">Piper N.Y., Bishoff J.T., Magee C. Is a 1-CM margin necessary during nephronsparing surgery for renal cell carcinoma? Urology 2001;58(6):849—52.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Akcetin Z., Zugor V., Elsasser D. Does the distance to normal renal parenchyma (DTNRP) in nephron-sparing surgery for renal cell carcinoma have an effect on survival? Anticancer Res 2005;25(3A):1629—32.</mixed-citation><mixed-citation xml:lang="ru">Akcetin Z., Zugor V., Elsasser D. Does the distance to normal renal parenchyma (DTNRP) in nephron-sparing surgery for renal cell carcinoma have an effect on survival? Anticancer Res 2005;25(3A):1629—32.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Duvdevani M., Laufer M., Kastin A. et al. Urology.Is frozen section analysis in nephron sparing surgery necessary? A clinicopathological study of 301 cases. J Urol 2005;173(2):385—7.</mixed-citation><mixed-citation xml:lang="ru">Duvdevani M., Laufer M., Kastin A. et al. Urology.Is frozen section analysis in nephron sparing surgery necessary? A clinicopathological study of 301 cases. J Urol 2005;173(2):385—7.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Kubinski D.J., Clark P.E., Assimos D.G., Hall M.C. Utility of frozen section analysis of resection margins during partial nephrectomy. Urology 2004;64(1):31—4.</mixed-citation><mixed-citation xml:lang="ru">Kubinski D.J., Clark P.E., Assimos D.G., Hall M.C. Utility of frozen section analysis of resection margins during partial nephrectomy. Urology 2004;64(1):31—4.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Timsit M.O., Bazin J.P., Thiounn N. et al. Prospective study of safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis. Urology 2006;67(5):923—6. Epub 2006 Apr 25.</mixed-citation><mixed-citation xml:lang="ru">Timsit M.O., Bazin J.P., Thiounn N. et al. Prospective study of safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis. Urology 2006;67(5):923—6. Epub 2006 Apr 25.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Thompson R.H., Leibovich B.C., Lohse C.M. Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol 2005;174(3):855—8.</mixed-citation><mixed-citation xml:lang="ru">Thompson R.H., Leibovich B.C., Lohse C.M. Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol 2005;174(3):855—8.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Ramani A.P., Desai M.M., Steinberg A.P. Complications of laparoscopic partial nephrectomy in 200 cases. J Urol 2005;173(1):42—7.</mixed-citation><mixed-citation xml:lang="ru">Ramani A.P., Desai M.M., Steinberg A.P. Complications of laparoscopic partial nephrectomy in 200 cases. J Urol 2005;173(1):42—7.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Meng M.V., Freise C.E., Stoller M.L. Laparoscopic nephrectomy, ex vivo excision and autotransplantation for complex renal tumors. J Urol 2004;172(2): 461—4.</mixed-citation><mixed-citation xml:lang="ru">Meng M.V., Freise C.E., Stoller M.L. Laparoscopic nephrectomy, ex vivo excision and autotransplantation for complex renal tumors. J Urol 2004;172(2): 461—4.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
